|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/52 | |||
| A61K 9/20 | |||
| A61K 9/24 | |||
| A61K 9/16 | |||
| A61K 9/48 | |||
| A61K 9/28 | |||
| A61K 31/5377 | |||
| A61K 9/00 | |||
| A61P 25/00 | |||
| A61P 25/20 | |||
| A61P 25/18 |
| (11) | Number of the document | 3572074 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19184602.1 |
| Date of filing the European patent application | 2011-03-30 | |
| (97) | Date of publication of the European application | 2019-11-27 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 28278710 P | 2010-03-31 | US |
| (72) |
CHANG, Rong-Kun, US
VIEIRA, Michael L., US
LIANG, Likan, US
BHATT, Padmanabh P., US
HUANG, Austin B., US
PATEL, Sachin V., US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
9715 Key West Avenue, Rockville, MD 20850,
US
|
| (54) | STABILIZED FORMULATIONS OF MOLINDONE |
| STABILIZED FORMULATIONS OF MOLINDONE |